Figures computed from official regulatory filings — .
Analysttarget 3.7 USD (+166%) · consensus 4/5 · 1 buy · 1 hold · 0 sell
Ownershipinsiders 19.39% · institutions 17.11% · short 6.2% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for 60 DEGREES PHARMACEUTICALS, INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
22 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| DOW GEOFFREY Strack record | Buy | $10.1K | conv 50 |
| DOW GEOFFREY Strack record | Buy | $7.7K | conv 38 | SEC |
| DOW GEOFFREY Strack record | Buy | $3.3K | conv 35 | SEC |
| DOW GEOFFREY Strack record | Buy | $8.9K | conv 49First in 12mo | SEC |
| DOW GEOFFREY Strack record | Award | $10K | SEC |
| Landon Kristen | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Landon Kristen | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DOW GEOFFREY Strack record | Award | $13.1K | SEC |
| XU CHERYLtrack record | Buy | $8.6K | conv 34 | SEC |
| XU CHERYLtrack record | Buy | $5.8K | conv 31 | SEC |
| DOW GEOFFREY Strack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MILLER TYRONE | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MILLER TYRONE | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DOW GEOFFREY Strack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| XU CHERYLtrack record | Buy | $2.3K | conv 22 | SEC |
| XU CHERYLtrack record | Buy | $2.4K | conv 22 | SEC |
| XU CHERYLtrack record | Buy | $2.3K | conv 22 | SEC |
| XU CHERYLtrack record | Buy | $2.9K | conv 22 | SEC |
| XU CHERYLtrack record | Buy | $2.4K | conv 22 | SEC |
| XU CHERYLtrack record | Buy | $4.5K | conv 26 | SEC |
| XU CHERYLtrack record | Buy | $4.6K | conv 26 | SEC |
| DOW GEOFFREY Strack record | Buy | $19.5K | conv 77Unusual size | SEC |
| DOW GEOFFREY Strack record | Buy | $24.7K | conv 67Unusual size | SEC |
| DOW GEOFFREY Strack record | Buy | $45.5K | conv 60Unusual size | SEC |
| DOW GEOFFREY Strack record | Buy | $3.2K | conv 39 | SEC |